Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel.
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder.
Noncirrhotic hyperammonemia causing relapsing altered mental status.
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biol Blood Marrow Transplant. 2020 07; 26(7):1239-1246.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Communicable Disease Control
Coronavirus Infections
Health Care Rationing
Humans
Immunotherapy, Adoptive
Lymphoma, B-Cell
Pandemics
Pneumonia, Viral
Practice Guidelines as Topic
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Receptors, Antigen, T-Cell
Tissue Donors
T-Lymphocytes
United States
authors with profiles
Michael Bishop
Peter Riedell